MARKET COMPOSITE
IKT - Inhibikase Therapeutics Inc4:00:00 AM 3/27/2024
Price
$2.30
+ 0.00 (0.00%)
Inhibikase is a clinical-stage pharmaceutical company developing therapeutics for Parkinson's disease and related disorders that arise inside and outside of the brain. Inhibikase is headquartered in Atlanta, Georgia with additional offices in Boston, Massachusetts.
Financials
Quarterly financials
(USD)Dec 2023Q/Q
Revenue1-100%
Operating Income-4.4MM-8%
Operating Expenses4.4MM-
Net Income-4.2MM-9%
R&D3MM-7%
G&A1.4MM-14%
Interest Expense--
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Stock news